XELOX combined with sintilimab and hyperbaric oxygen therapy for advanced or metastatic gastric/gastroesophageal junction adenocarcinoma: study protocol for a prospective, single-arm, phase Ib/II clinical trial
XELOX combined with sintilimab and hyperbaric oxygen therapy for advanced or metastatic gastric/gastroesophageal junction adenocarcinoma: study protocol for a prospective, single-arm, phase Ib/II clinical trial
M. Liu, P. Zhang, Jing Wei, Lin Zhu et al.
Journal
Frontiers in Immunology
Topics
Esophageal Cancer Research and Treatment
article
XELOX combined with sintilimab and hyperbaric oxygen therapy for advanced or metastatic gastric/gastroesophageal junction adenocarcinoma: study protocol for a prospective, single-arm, phase Ib/II clinical trial
M. Liu, P. Zhang, Jing Wei, Lin Zhu, Mo Cheng, W. Li, Menghui Xu, Sihui Song, Dan Li, Cheng Huang
article en
Abstract
No abstract available for this paper.
Publication Tag
Frontiers in ImmunologyVol. 16
Institutions
Sichuan University (CN), West China Hospital of Sichuan University (CN), Sichuan Cancer Hospital (CN)
Funders
Sichuan University, West China Hospital, Sichuan University
Ask Laika to Summarize, Analyze, and Connect papers live on the map.
Summarize Papers & Methodologies
Extract key findings, datasets, and comparative methods across publications.
Benchmark Rankings & Visual Analytics
Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.
Connect Distant Disciplines
Bridge topological clusters on the map to find hidden collaborative intersections.
XELOX combined with sintilimab and hyperbaric oxygen therapy for advanced or metastatic gastric/gastroesophageal junction adenocarcinoma: study protocol for a prospective, single-arm, phase Ib/II clinical trial — M. Liu, P. Zhang, et al. · Frontiers in Immunology (2026) | TGRS Research Map | TGRS